ArticleViruses2023

Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV.

Maria Mazzitelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.